Morin Reactivates Nrf2 by Targeting Inhibition of Keap1 to Alleviate Deoxynivalenol-Induced Intestinal Oxidative Damage

被引:1
|
作者
Zan, Gengxiu [1 ]
He, Hui [1 ]
Wang, Xiaofan [1 ]
Zhou, Jiayi [1 ]
Wang, Xiuqi [1 ]
Yan, Huichao [1 ]
机构
[1] South China Agr Univ, Coll Anim Sci, Natl Engn Res Ctr Breeding Swine Ind, State Key Lab Swine & Poultry Breeding Ind,Guangdo, Guangzhou 510642, Peoples R China
基金
中国国家自然科学基金;
关键词
deoxynivalenol; Morin; intestinal stem cells; oxidative stress; Keap1/Nrf2 signaling pathway; HO-1; EXPRESSION; STRESS; ANTIOXIDANT; INDUCTION;
D O I
10.3390/ijms26031086
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
As a prevalent mycotoxin found in cereal foods and feed, deoxynivalenol (DON) disrupts the orderly regeneration of intestinal epithelial tissue by interfering with the intracellular antioxidant defense system. However, the potential of mulberry leaf-derived Morin, a natural flavonoid active substance with clearing reactive oxygen species (ROS), to mitigate DON-induced intestinal oxidative damage remains unclear. Our investigation demonstrates that Morin effectively reverses the decline in growth performance and repairs damaged jejunal structures and barrier function under DON exposure. Furthermore, the proliferation and differentiation of intestinal stem cells (ISCs) is enhanced significantly after Morin intervention. Importantly, Morin increases the levels of total antioxidant capacity (T-AOC), superoxide dismutase (SOD), and glutathione peroxidase (GSH-PX) in the serum and jejunal tissue, while reducing the accumulation of ROS and malondialdehyde (MDA). Molecular interaction analysis further confirms that Morin targets inhibition of Keap1 to activate the Nrf2-mediated antioxidant system. In summary, our results suggest that Morin alleviates the oxidative damage induced by DON by regulating the Keap1/Nrf2 pathway, thereby restoring the proliferation and differentiation activity of ISC, which provides new insights into Morin mitigating DON damage.
引用
收藏
页数:13
相关论文
共 50 条
  • [31] Engeletin Attenuates Aβ1–42-Induced Oxidative Stress and Neuroinflammation by Keap1/Nrf2 Pathway
    Zhixiong Huang
    Hu Ji
    Junfeng Shi
    Xinchen Zhu
    Zhongwen Zhi
    Inflammation, 2020, 43 : 1759 - 1771
  • [32] Modulation of NRF2/KEAP1 Signaling in Preeclampsia
    Tossetta, Giovanni
    Fantone, Sonia
    Piani, Federica
    Crescimanno, Caterina
    Ciavattini, Andrea
    Giannubilo, Stefano Raffaele
    Marzioni, Daniela
    CELLS, 2023, 12 (11)
  • [33] Development of inhibitors of the Keap1/Nrf2 interactions
    Jain, Atul D.
    Potteti, Haranatha R.
    Reddy, Sekhar
    Moore, Terry W.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2014, 248
  • [34] Structural basis of Keap1 interactions with Nrf2
    Canning, Peter
    Sorrell, Fiona J.
    Bullock, Alex N.
    FREE RADICAL BIOLOGY AND MEDICINE, 2015, 88 : 101 - 107
  • [35] Engeletin Attenuates Aβ1-42-Induced Oxidative Stress and Neuroinflammation by Keap1/Nrf2 Pathway
    Huang, Zhixiong
    Ji, Hu
    Shi, Junfeng
    Zhu, Xinchen
    Zhi, Zhongwen
    INFLAMMATION, 2020, 43 (05) : 1759 - 1771
  • [36] Resveratrol targeting NRF2 disrupts the binding between KEAP1 and NRF2-DLG motif to ameliorate oxidative stress damage in mice pulmonary infection
    Chi, Fuyun
    Cheng, Chuanjing
    Zhang, Man
    Su, Bo
    Hou, Yuanyuan
    Bai, Gang
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 332
  • [37] Targeting Keap1 with Inulae Herba activated the Nrf2 receptor to alleviate LPS-mediated acute lung injury
    Zhang, Juan
    Liu, Jing
    Liu, Jing-Wen
    Zhu, Qi-Meng
    Zhang, Min
    Zhang, Rui
    Ma, Xiao-Chi
    Lv, Xia
    Yu, Zhen-Long
    Sun, Cheng-Peng
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 319
  • [38] Protection of Porcine Intestinal-Epithelial Cells from Deoxynivalenol-Induced Damage by Resveratrol via the Nrf2 Signaling Pathway
    Yang, Jun
    Zhu, Cui
    Ye, Jinling
    Lv, Yantao
    Wang, Li
    Chen, Zhuang
    Jiang, Zongyong
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2019, 67 (06) : 1726 - 1735
  • [39] Fragment-based Drug Discovery Targeting KEAP1/Nrf2 Binding
    Zhong, Mengqi
    Lynch, Andrew
    Jehle, Stefan
    Kozakov, Dima
    Vajda, Sandor
    Allen, Karen
    Whitty, Adrian
    FASEB JOURNAL, 2015, 29
  • [40] Potential Benefits of Nrf2/Keap1 Targeting in Pancreatic Islet Cell Transplantation
    Jarrin Lopez, Alberto
    Lau, Hien
    Li, Shiri
    Ichii, Hirohito
    ANTIOXIDANTS, 2020, 9 (04)